AGT and myocardial infarction: miR-34a has been suggested both as a potential biomarker and a therapeutic target for cardiac remodelling, following several conditions such as acute myocardial infarction and anthracycline-induced cardiotoxicity, but it has not been directly associated with fibrosis secondary to Ang II stimulation [219,220,221,222,223].